Jaebadiah S. Gardner

Jaebadiah S. Gardner is an African-American, Mexican-American business man, multi-family real estate developer, author and is the Founder & CEO of GardnerGlobal, Inc., a privately held holding company. Jaebadiah earned a bachelor’s degree from the University of Washington and later earned a Juris Doctor (J.D.) degree from Western Michigan Law School. Prior to development Jaebadiah worked for Turner Construction building commercial high-rises in downtown Seattle. He has built up a client base of private and non-profit clients in the real estate development space providing feasibility, pre-development and development services. Jaebadiah latest projects consist of the development of the Liberty Bank Building in Seattle’s Central District; a $33 million dollar, 115-unit affordable housing building. Additionally, GardnerGlobal currently has over $9M dollars of land under contract in the city of Seattle with $125 million dollars of future development opportunity that will yield 600+ units of future market rate, workforce and affordable housing. Jaebadiah most recently lead the efforts to close a $3.75 million dollar land acquisition deal in the Central district where he looks to develop 170 units of mixed income housing. Jaebadiah specializes in bringing together government, private capital, community and design partners to overcome complex project hurdles. He has served as a part-time instructor for the University of Washington, Bellevue College and Seattle Central College. He currently serves as a Board of Trustee for the Seattle Metropolitan Chamber of Commerce and President of the University of Washington MAP Board. Jaebadiah’s focus is building wealth through investments, partnerships and community.

Claudia Bellony Atanga

As the developer of Programming at the International Economic Development Council (IEDC), Claudia Bellony-Atanga creates and builds the robust content for IEDC’s conferences.  She also leads IEDC’s Higher Education Advisory Committee as their staff liaison. Claudia is an advocate for economic equity, women empowerment and equality, entrepreneurship, with data-driven results. She uses creative endeavors to maximize and improve the work in community and economic development.

Karin Barthelmes-Wehr

Karin Barthelmes-Wehr is Managing Director of the Institute for Corporate Governance in the German Real Estate Industry (ICG) – the leading Think and Do Tank for all topics related to sustainable leadership. She has been involved in building up the institute since 2003.

 

Karin is also Chair of the International Ethics Standards Coalition which was initiated by the United Nations in 2014. The coalition’s aim is to establish and implement a common code of ethics in the real estate industry worldwide. To date, around 150 real estate bodies from almost 50 countries (as well as just as many companies, universities and government organisations) have joined the coalition.

 

Apart from other honorary appointments, Karin is member of the advisory committee of the Real Estate Department of HAWK (Hildesheim/Holzminden University of Applied Sciences), a juror for the polis AWARD and founding member and mentor at the cross industry program Initiative Women into Leadership (IWiL). She holds a Master’s degree (suma cum laude) in English, Romance Philology and Political Science from the University of Münster and has more than 25 years of experience in the real estate industry. Before joining ICG, Karin worked in real estate conference management for EUROFORUM/”Handelsblatt” and in executive search at Heidrick & Struggles. In 2020, the jury of “Immobilien Manager” selected her as the top 1 “Real Estate Influencer”, the category of “Real Estate Women with a Strong Presence and High Reputation”.

Nari Yun

Dr. Yun began her career at Hanmi Pharmaceuticals, took the major role in managing all activities associated with the clinical development programs for key assets including long-acting insulin, GLP-1 agonist and GLP-1/GCG dual agonist. She engaged in full courses of drug development, ranging from CDP/TPP development, clinical strategy formulation and operations, licensing out and co-development with partners. She also served as a strategic consultant in IQVIA, worked on consulting projects for key business decisions, including business planning and strategy formulation, asset valuation and pricing & reimbursement strategy for various drugs etc.

In September 2019, Dr. Yun joined to GI Innovation and has led clinical collaboration agreement of company’s immunooncology asset with global pharmaceutical companies, including MSD and AstraZeneca. She is now serving as a head of clinical development.

Dr. Yun is a registered pharmacist in Korea and was educated at School of Pharmacy, Sunkyunkwan University, where she received her PhD in pharmacology in 2012.

Gareth Presch

Gareth is a global healthcare thought leader and the Founder and CEO of the World Health Innovation Summit. He is the Expert Lead on SDG3/4 for the UNGSII Foundation 25+5 SDG Cities Leadership Platform, Founder of the Global Social Prescribing Alliance, and a Member of Pope Francis’s Vatican COVID19 Commission Group 2 Looking to the Future.